Medical Health Related Tech Calls | Innoget

Find Tech Calls related to Medical Health, Medical, Health, Anatomy, Physiology, Oncology, Pharmaceuticals, Biotechnology and Immunology posted on Innoget

  1. Home
  2. Technology Calls
  3. Medical Health related

Juli Ramon posted this Technology Call
Account Manager at GCCIR

As a participant of the upcoming symposium “GCCIR Matchmaking Symposium” organized by the GCCIR and Innoget next 19 November 2018 in Barcelona (Spain), the company Innovative Trauma Care Inc. (iTraumaCare) is seeking European partners to meet at the Barcelona event to jointly develop R&D projects. As an alternative to hemostatic bandages, iTraumaCare is developing a medical hemostatic glove adapted to tightly conform over a donned medical barrier glove. The External Hemostatic Gloves for Hemorrhage Control device is designed for use in a field (or surgical) environment that provides a means to combine the advantages of applying a hemostatic dressing with the simplicity of applying a traditional manual pressure via a gloved hand. iTraumaCare is specifically interested in collaborating with partners in the following areas: I. To enable the hemostasis function of the glove, a protected hemostatic agent is required. Being that the IP and regulatory burden for hemostatic agents is quite involved, it would be of interest for iTraumaCare to have a partner that has previously worked with, has regulatory clearance with and has IP associated with one or more hemostatic agents. II. As a complement to the hemostasis function of the glove material, additional pharmacologically and biologically active agents could be absorbed to the glove, including but not limited to, antifibrinolytics, styptics, antibacterial agents, antimicrobial agents, analgesic and anaesthetic agents for treatment. A company that has interest with, regulatory clearance with and IP protection of such areas would be of interest. Additional regulatory clearance would be required for the different formulations with different indications for use, so partners with regulatory cleared chemistry would be preferred. As a product class, these combination products could lead to multiple and varied products for sale. III. To create a hemostatic glove, raw materials manufactures will be required. Manufacturers with IP in development for unique manufacturing of hemostatic fibres, acting like a tightly conforming hemostatic bandage, the actions of the surgeon’s physician’s, warfighter’s or medic’s hands and fingers applying manual pressure will also accelerate hemostasis chemically. Material manufacturers for hemostatic gloves can be used similar to most of the current sources materials for hemostatic bandages such as packing into wounds for contact hemostasis, wherein the glove can be removed from the caregiver’s hands and temporarily inserted into the wound to temporize blood loss. In case you are interested in meeting iTraumaCare at the Barcelona event to discuss a potential collaboration, please register for free to the symposium through the orange button provided above.
Seeking European partners to develop a novel medical hemostatic glove to tightly conform over a donned medical barrier glove

Haier posted this Technology Call

Nowadays, consumers are more and more concerned about food safety and health. Food even stored properly may still grow bacteria with time goes on. So now we are seeking for technologies or solutions that can detect the total microbial counts in a closed space that can be integrated with refrigerator. The module shall be small in size and have a relatively long lifetime, as the lifetime of a refrigerator is 8-10 years. Currently, we do not set specific requirement for the detection accuracy. It would be accepted as long as it could detect and tell the total bacteria counts. Haier prefers to work with partners that have existing technologies or approaches that can be applied to this specific application. Collaboration can involve technology licensing, product sourcing, proof of concept leading to joint development agreements and assistance with scale-up to manufacturing. Preference will be given to technologies or approaches that currently have working prototypes that can undergo feasibility, validation or proof of concept over a 3-6 month period. Financial support for the proof of concept phase will be negotiated based on specific performance targets agreed between both parties. For selected collaborators Haier may provide access to samples, test equipment and testing facilities. Technologies will need to satisfy manufacturability, material cost and ease of use assessments to progress from the concept stage.
Seeking for bacteria detection method used in closed space